The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 841–864 of 11,281
ArticleMDMA

Acute Coronary Syndrome and Recreational Drug Use: A Comprehensive Review.

Iliakis P, Ntalekou K, Stamou E +14

Europe PMC2026
ArticleKetamine

A scoping review for published guidelines for use of ketamine in chronic non-cancer pain.

Daff MLM, Eblen SA, Somogyi AA +2

Europe PMC2026
ArticleKetamine

The application of esketamine in cancer-related depressive states: attention from mechanisms to clinical translation.

Chen L, Chen Y, Zhao Y +7

Europe PMC2026
ArticleKetamine

Intranasal esketamine for ECT-refractory bipolar depression: a case report.

Abbas M, Kallas B, Garris M

Europe PMC2026
ArticleKetamine

Brivaracetam in Combination with Midazolam and Ketamine Reduces Soman-Induced Seizure and Neurodegeneration in Rats.

Lumley LA, Steier HG, Orta SY +6

Europe PMC2026
ArticleKetamine

Interpreting Perineural Esketamine for Analgesia After Total Knee Arthroplasty: Methodological and Reporting Considerations [Letter].

Zhou Z, Li Y, Lu J

Europe PMC2026
ArticleKetamine

Comment on "The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis".

Nair AS, Mistry T

Europe PMC2026
PreprintPsilocybin

Beyond psilocybin: Do magic mushroom preparations contain other compounds with pharmacological effects?

Lasham S, P B, W E +3

Europe PMC2026
ArticlePsilocybin

Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica.

Sams CH, Davis J, Ramdas A +4

Europe PMC2026
ArticleKetamine

Rethinking Ketamine: The Effect of Postoperative Ketamine Infusions on Pain and Opioid Consumption Following Major Limb Amputation.

Chavez D, Nguyen A, Otoya D +6

Europe PMC2026
ArticleKetamine

Psychoactive and Neurobiological Effects of Ketamine in Humans: A Scoping Review of Clinical Evidence.

Turtulli S, Papadaki E

Europe PMC2026
ArticleKetamine

Development and validation of an enzyme immunoassay screen and achiral/chiral LC-MS/MS confirmation methods for ketamine analysis in hair.

Stowe GN, Loni E, Gonzalez A +2

Europe PMC2026
ArticleKetamine

Electroencephalographic Patterns Associated with the Pharmacokinetics and Pharmacodynamics of GABAergic Agents, Opioids, and Ketamine During General Anesthesia: A Systematic Review.

Girombelli A, Volpe P, Saglietti F +4

Europe PMC2026
ArticleKetamine

Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions.

Wilkowska A, Nizgorska-Ohler J, Cubała WJ

Europe PMC2026
ArticleKetamine

Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics.

Jones GH, Gilbert JR, Johnston JN +20

Europe PMC2026
ArticleIbogaine

Feasibility, safety and preliminary effects of ibogaine in patients with moderate and severe alcohol use disorder: a pilot, open-label study.

Rocha JM, Maekawa RM, Reis JAS +9

Europe PMC2026
ArticleLSD

High-sensitivity immunochromatographic assay based on time-resolved fluorescence microspheres for the simultaneous detection of mescaline and LSD in hair.

Yang M, Wen W, Yang H +3

Europe PMC2026
ArticleKetamine

Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression: A Real-World Cohort Study.

Singh B, Leung JG, Pazdernik VK +2

Europe PMC2026
ArticleKetamine

Dimensional effect profiles in treatment-resistant depression: A naturalistic, prospective head-to-head comparison of arTMS, esketamine nasal spray, and oral brexpiprazole.

d'Andrea G, Cavallotto C, Susini O +10

Europe PMC2026
PreprintPsilocybin

Identifying factors that contribute to the behavioral effects of psilocybin in preclinical mouse models

Fleury S, Chang LJ, Nautiyal KM

Europe PMC2026
ArticlePsilocybin

Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex.

Wawrzczak-Bargieła A, Jelonek-Kozioł M, Kumorek W +2

Europe PMC2026
ArticleKetamine

Intravenous Ketamine for Depressed and Suicidal Adolescents in the Emergency Department: A Randomized Double-Blind Trial

Vayngortin T, Patel E, Seneviratne S +6

Europe PMC2026
PreprintDMT

Protective Role of Dimethyltryptamine in Preserving Donor Heart Function in a Heterotopic Rat Transplantation Model

Csonka M, Damenija G, Stengl R +11

Europe PMC2026
ArticleKetamine

Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.

McIntyre RS, Kato M, Thase ME +5

Europe PMC2026